Proteins and peptides have taken center stage as leading therapeutic candidates. The increased demand for new protein and peptide therapeutics requires powerful bioanalytical techniques with high sensitivity and robustness to test drug safety and efficacy. High-resolution accurate mass spectrometry (HRAMS) provides high selectivity but is often limited in its sensitivity. In this webinar, Shane Needham will discuss protein quantification workflow optimization and introduce a new HRAMS system with increased sensitivity and robustness.

Topics to be covered

• Improving the sensitivity of protein quantification workflows
• Analyzing complex structures with improved fragmentation methods
• Quantifying intact proteins using simplified MS protocols


  • 1627474115-4a2cbe7b204c02bc
    Shane Needham, PhD
    Director, Alturas Analytics, Inc. and Needham Scientific, Inc.
    Shane Needham received his BS degree in chemistry from Washington State University and his PhD in chemistry from the University of Rhode Island. He has nearly 30 years of experience in applying bioanalytical good laboratory practices for LC-MS/MS and has more than 200 publications in the field. Needham is founder, owner, and director of Alturas Analytics, Inc. and Needham Scientific, Inc. based in Moscow, ID.
  • E
    Eshani Nandita